504 related articles for article (PubMed ID: 1519673)
1. Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model.
Ross JS; Bui HX; del Rosario A; Sonbati H; George M; Lee CY
Am J Pathol; 1992 Sep; 141(3):721-7. PubMed ID: 1519673
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori affects the quality of experimental gastric ulcer healing in a new animal model.
Bui HX; del Rosario A; Sonbati H; Lee CY; George M; Ross JS
Exp Mol Pathol; 1991 Dec; 55(3):261-8. PubMed ID: 1748215
[TBL] [Abstract][Full Text] [Related]
3. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
[TBL] [Abstract][Full Text] [Related]
4. [Helicobacter pylori in peptic ulcer and gastric cancer].
Matsukura N; Onda M; Yamashita K
Gan To Kagaku Ryoho; 1995 Feb; 22(2):169-78. PubMed ID: 7857088
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.
Jhala D; Jhala N; Lechago J; Haber M
Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993
[TBL] [Abstract][Full Text] [Related]
6. Gastric secretion and ulcer healing in mouse stomach infected with cytotoxin expressing strain of Helicobacter pylori.
Brzozowski T; Konturek PC; Konturek SJ; Karczewska E; Pajdo R; Stachura J; Ghiara P; Hahn EG
J Physiol Pharmacol; 1998 Sep; 49(3):387-403. PubMed ID: 9789792
[TBL] [Abstract][Full Text] [Related]
7. Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease.
Taha AS; Curry GW; Morton R; Park RH; Beattie AD
Am J Gastroenterol; 1996 Jul; 91(7):1407-9. PubMed ID: 8678004
[TBL] [Abstract][Full Text] [Related]
8. Histopathological changes in gastric mucosa colonized by H. pylori.
Kumar A; Bansal R; Pathak VP; Kishore S; Karya PK
Indian J Pathol Microbiol; 2006 Jul; 49(3):352-6. PubMed ID: 17001883
[TBL] [Abstract][Full Text] [Related]
9. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
10. Cellular proliferation and ploidy of the gastric mucosa: the role of Helicobacter pylori.
Abdel-Wahab M; Attallah AM; Elshal MF; Abdel-Raouf M; Zalata KR; el-Ghawalby N; Ezzat F
Hepatogastroenterology; 1997; 44(15):880-5. PubMed ID: 9222708
[TBL] [Abstract][Full Text] [Related]
11. Size of the peptic ulcer in Helicobacter pylori-positive patients: association with the clinical and histological characteristics.
Arkkila PE; Kokkola A; Seppälä K; Sipponen P
Scand J Gastroenterol; 2007 Jun; 42(6):695-701. PubMed ID: 17505991
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers.
Lin HJ; Lo WC; Perng CL; Li AF; Tseng GY; Sun IC; Ou YH
Helicobacter; 2004 Dec; 9(6):663-8. PubMed ID: 15610081
[TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
Romano M; Ricci V; Di Popolo A; Sommi P; Del Vecchio Blanco C; Bruni CB; Ventura U; Cover TL; Blaser MJ; Coffey RJ; Zarrilli R
J Clin Invest; 1998 Apr; 101(8):1604-13. PubMed ID: 9541490
[TBL] [Abstract][Full Text] [Related]
14. [Morphologic changes of gastric mucosa in Helicobacter pylori infection in patients with peptic ulcer disease and chronic gastritis].
Raczyńska A; Jarczyk G; Jarczyk J; Jedrzjczyk W
Pol Merkur Lekarski; 1996 Sep; 1(3):165-8. PubMed ID: 9139779
[TBL] [Abstract][Full Text] [Related]
15. Experimental Helicobacter pylori infection induces antral-predominant, chronic active gastritis in hispid cotton rats (Sigmodon hispidus).
Mähler M; Heidtmann W; Niewiesk S; Gruber A; Fossmark R; Beil W; Hedrich H; Wagner S
Helicobacter; 2005 Aug; 10(4):332-44. PubMed ID: 16104950
[TBL] [Abstract][Full Text] [Related]
16. Experimental production of peptic ulcer, gastric damage and cancer models and their use in pathophysiological studies and pharmacological treatment--Polish achievements.
Brzozowski T
J Physiol Pharmacol; 2003 Dec; 54 Suppl 3():99-126. PubMed ID: 15075467
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease.
Kato S; Nishino Y; Ozawa K; Konno M; Maisawa S; Toyoda S; Tajiri H; Ida S; Fujisawa T; Iinuma K
J Gastroenterol; 2004 Aug; 39(8):734-8. PubMed ID: 15338366
[TBL] [Abstract][Full Text] [Related]
18. Rationale for eradication of Helicobacter pylori infection in duodenal ulcer disease.
Malfertheiner P; Domínguez-Muñoz JE
Clin Ther; 1993; 15 Suppl B():37-48. PubMed ID: 8205594
[TBL] [Abstract][Full Text] [Related]
19. [Helicobacter pylori--an etiopathogenic factor of stomach and duodenal diseases among children].
Czerwionka-Szaflarska M; Mierzwa G; Bała G
Pediatr Pol; 1995 Jul; 70(7):563-8. PubMed ID: 8649954
[TBL] [Abstract][Full Text] [Related]
20. Comparison of pathologic changes in Helicobacter pylori-infected Mongolian gerbils and humans.
Sawada Y; Yamamoto N; Sakagami T; Fukuda Y; Shimoyama T; Nishigami T; Uematsu K; Nakagawa K
J Gastroenterol; 1999; 34 Suppl 11():55-60. PubMed ID: 10616767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
